2005
Measuring Physician Productivity, Eliot L. Friedman MD and Teri Guidi (Article)
Tuberculosis of sacroiliac joint: an unusual presentation., Ranju Gupta MD, Harry Bienenstock, Placido Morano, and Anil Gupta (Article)
Should Elderly Non-Small-Cell Lung Cancer Patients be Offered ElderlySpecific Trials? Results of a Pooled Analysis from the North Central Cancer Treatment Group., Aminah Jatoi, Shauna L. Hillman, Philip J. Stella MD, Erin Green, Alex A. Adjei, Suresh G. Nair MD, Edith A. Perez MD, Bipinkur Amin, Steven E. Schild, Rene Castillo, and James R. Jett (Article)
Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation., Irina Kakhniashvili, Joanne Filicko, Walter K Kraft, and Neal Flomenberg (Article)
A Rare Case of Primary Amyloidosis, Presenting with Severe Pulmonary Hypertension and Bilateral Pleural Effusion, Maged Khalil MD (Article)
Multiple Myeloma Presenting as Pulmonary, Gastric and Epidural Extramedullary Plasmacytomas: Synchronous Presentation., Maged Khalil MD (Article)
Plasmapheresis as a Therapeutic Option for Castleman’s Disease [CD]., Maged Khalil MD (Article)
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass., Maged Khalil MD, Padjama Sai, Zili He, Ashraf Aziz, William Steier, Shetra Sivamurthy, Ming Liu, and Madhumati Kalavar (Article)
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature., Maged Khalil MD, Asha Thomas, Adel Aassad, Moshe Rubin, and Robert N Taub (Article)
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience., Andre Konski, John Hoffman, Elin Sigurdson, Oleh Haluszka, Paul Engstrom, Jonathan D Cheng, Steven J Cohen, James C Watson, Debra Eisenberg, Eileen McGarrity, Gary Freedman, and Neal J Meropol (Article)
Detection and partial characterization of a broad-range bacteriocin produced by Lactobacillus plantarum (ATCC 8014), Bradley Lash (Article)
Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine as Front-Line Therapy for Advanced Non-Small-Cell Lung Cancer., Cynthia X Ma, Suresh G. Nair MD, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch MD, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, and Alex A. Adjei (Article)
Immune Monitoring, Paul Mosca, T M. Clay, M A. Morse, and H K. Lyerly (Book Chapter)
N0234: Phase II study of erlotinib (OSI-774) plus gemcitabine as first-or second-line therapy for metastatic breast cancer (MBC), Suresh G. Nair MD (Article)
Factors that Influence Colorectal Cancer Screening Practice in the Latino Community, Ana Natale-Pereira MD, MPH; Marielos Vega RN, BSN; Jonnie Marks PhD; Debbie Salas-Lopez MD, MPH; and M S. Johnson (Presentation)
Perspectives on Cancer Screening Among Internal Medicine Residents and Latino Community Members: A Work in Progress, Debbie Salas-Lopez MD, MPH; Dawne M. Mouzon MPH; Ana Natale-Pereira MD, MPH; Vincent J. Barba; John Kolassa; Jonnie Marks PhD; and Maria L. Soto-Greene MD (Presentation)
Global gene expression profiling of circulating tumor cells., Denis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, M Craig Miller, Gerald V Doyle, Kenneth J Pienta, Neal J Meropol, Louis M Weiner, Steven J Cohen, Jose G Moreno, Mark C Connelly, Leon W M M Terstappen, and S Mark O'Hara (Article)
Changing patterns of bone and brain metastases in patients with colorectal cancer., Mark L Sundermeyer, Neal J Meropol, Andre Rogatko, Hao Wang, and Steven J Cohen (Article)
2004
Gemcitabine and ISIS-2503 for Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial., Steven R. Alberts MD, MPH; Mark Schroeder; Charles Erlichman; Preston D. Steen MD; Nathan R. Foster; Dennis F. Moore; Kendrith M. Rowland; Suresh G. Nair MD; Loren K. Tschetter; and Tom R. Fitch MD (Article)
Characterization of two novel BRCA1 germ-line mutations involving splice donor sites., M S Brose, P Volpe, K Paul, J E Stopfer, T A Colligon, K A Calzone, and B L Weber (Article)
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer., Steven J Cohen, James Gallo, Nancy L Lewis, R Katherine Alpaugh, Louis Gentner, André Rogatko, Gwen Yeslow, Jessie Schol, Tom Verhaeghe, Peter Zannikos, Peter A Palmer, Louis M Weiner, and Neal J Meropol (Article)
Absence of BRAF mutations in UV-protected mucosal melanomas., R H Edwards, M R Ward, H Wu, C A Medina, M S Brose, P Volpe, S Nussen-Lee, H M Haupt, A M Martin, M Herlyn, S R Lessin, and B L Weber (Article)
Accelerated immune reconstitution using LLME treated donor lymphocyte infusions, Joanne Filicko (Article)
T cell repertoire complexity is conserved after L-leucyl-L-leucine methyl ester (LLME) treatment of donor lymphocyte infusions, Joanne Filicko (Article)
The Use of TCR Vβ Spectratype Analysis in Allogeneic Blood and Marrow Transplantation., Joanne Filicko (Article)
A COMPUTER-BASED DECISION AID IS AN EFFECTIVE TOOL FOR EDUCATING WOMEN SEEKING INFORMATION ABOUT BRCA1/2 GENETIC TESTING., M J. Green; S K. Peterson; M W. Baker; Gregory R. Harper MD, PhD; L C. Friedman; W S. Rubinstein; and D T. Mauger (Article)
Cytoprotection in acute myelogenous leukemia (AML) therapy., Dolores Grosso, Joanne Filicko, Guillermo Garcia-Manero, Frank Beardell, Janet Brunner, Jeffrey Cohn, Andres Ferbér, José Martinez, Bijoyesh Mookerjee, Lewis Rose, David Tice, John L Wagner, Robert Capizzi, and Neal Flomenberg (Article)
A Case of IgM- λ Waldenström’s Macroglobulinemia with Activity Against Phospholipids, Masquerading as Factor V Inhibitor., Ranju Gupta MD (Article)
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines., Christiane Houde, Yulin Li, Lynda Song, Kevin Barton, Qing Zhang, John Godwin, Sucha Nand, Amir Toor MD, Serhan Alkan, N Veronique Smadja, Hervé Avet-Loiseau, Carmen S Lima, Lucio Miele, and Lionel J Coignet (Article)
Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers., J Huang, S M Domchek, M S Brose, T R Rebbeck, K L Nathanson, and B L Weber (Article)
Investigating Four 'Myths' Surrounding Dysphagia in Patients with Metastatic Esophageal Cancer. A Multi-Institutional Study from the North Central Cancer Treatment Group., Aminah Jatoi, Nathan R. Foster, P Johnson, George G. Klee, J F Quevedo, Roscoe F. Morton MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James A. Mailliard MD (Article)
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients with Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort., Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Jeff A. Sloan, Shaker R. Dakhil MD, Neil MacDonald, Bruno Gagnon, Paul J. Novotny, James A. Mailliard MD, Teresita I L Bushey, Suresh G. Nair MD, and Brad Christensen (Article)
Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity., Anne Kanard, Aminah Jatoi, Rene Castillo, Susan Geyer, Thomas K. Schulz, Tom R. Fitch MD, Kendrith M. Rowland, Suresh G. Nair MD, James E. Krook MD, and John W. Kugler MD (Article)
Utility of Prophylactic Autologous Stem Cell Collection for Patients with Acute Myeloid Leukemia in First Remission., M Kasner (Article)
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis., Maged Khalil MD, William D Wagner, and Ira J Goldberg (Article)
Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): a Trial of the Eastern Cooperative Oncology Group., Corey J. Langer, Yi Li, Timothy Jennings, Ronald C. DeConti, Suresh G. Nair MD, Roger B. Cohen, and Arlene A. Forastiere (Article)
Effect of aromatase inhibitor therapy on cognitive function, I Makhoul, P Eslinger, Dan Popescu MD, H Harvey, K Parkinson, and A Lipton (Article)
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study., G L Phillips, B Meisenberg, D E Reece, V R Adams, A Badros, J Brunner, R Fenton, J Filicko, D Grosso, G A Hale, D S Howard, V P Johnson, A Kniska, K W Marshall, R Nath, E Reed, A P Rapoport, N Takebe, D H Vesole, J L Wagner, and N Flomenberg (Article)
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma., G L Phillips, B R Meisenberg, D E Reece, V R Adams, A Z Badros, J L Brunner, R G Fenton, J Filicko, D L Grosso, G A Hale, D S Howard, V P Johnson, A Kniska, K W Marshall, B Mookerjee, R Nath, A P Rapoport, C Sarkodee-Adoo, N Takebe, D H Vesole, J L Wagner, and N Flomenberg (Article)
Post-transplant air-leak syndrome., Tawee Tanvetyanon, Amir Toor MD, and Patrick J Stiff (Article)
Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma., Amir Toor MD, John Ayers, Joan Strupeck, Mala Parthasarathy, Steve Creech, Tulio Rodriguez, and Patrick J Stiff (Article)
2003
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma., Steven J Cohen, Linus Ho, Sulabha Ranganathan, James L Abbruzzese, R Katherine Alpaugh, Mary Beard, Nancy L Lewis, Susan McLaughlin, André Rogatko, Juan J Perez-Ruixo, Amanda M Thistle, Tom Verhaeghe, Hao Wang, Louis M Weiner, John J Wright, Gary R Hudes, and Neal J Meropol (Article)
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective., Julian P Cooney, Patrick J Stiff, Amir Toor MD, and Mala Parthasarathy (Article)
Infection--an underappreciated cause of bone pain in multiple myeloma., Raman Desikan, Bart Barlogie, Rajesh Sethi, Amir Toor MD, Dan Spoon, Edward Angtuaco, Rudy Vanhemert, Anantha VijayaGopal, Seema Singhal, Jayesh Mehta, Sundar Jagannath, Nikhil Munshi, Maurizio Zangari, Athanassios Fassas, Guido Tricot, and Elias Anaissie (Article)
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment., J Filicko, H M Lazarus, and N Flomenberg (Article)
Sensorineural hearing loss associated with intrathecal vancomycin., Olga M Klibanov, Joanne E Filicko, Joseph A DeSimone, and David S Tice (Article)
Impact of Immediate Reconstruction on the Local Recurrence of Breast Cancer After Mastectomy., Robert X. Murphy JR, MD, MS; Samina Wahhab MD; Peter Rovito MD; Gregory R. Harper MD, PhD; Sharon R. Kimmel; Lawrence C. Kleinman MD, MPH; and Mark J. Young MD (Article)
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation., Kapaettu Satyamoorthy, Gang Li, Michelle R Gerrero, Marcia S Brose, Patricia Volpe, Barbara L Weber, Patricia Van Belle, David E Elder, and Meenhard Herlyn (Article)
2002
CPT-11 for Bile-Duct and Gallbladder Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Study., Steven R. Alberts MD, MPH; Paul A. Fishkin; Lawrence J. Burgart; Peter J. Cera; Michelle R. Mahoney; Roscoe F. Morton MD; Patricia A. Johnson; Suresh G. Nair MD; and Richard M. Goldberg (Article)
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning., Ashraf Badros, Guido Tricot, Amir Toor MD, Christopher Morris, Chuanfa Guo, Nikhil Munshi, Bart Barlogie, and Michele Cottler-Fox (Article)
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program., Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, and Barbara L Weber (Article)
BRAF and RAS mutations in human lung cancer and melanoma., Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, and Barbara L Weber (Article)
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer., Steven J Cohen, Cynthia G Leichman, Gwen Yeslow, Mary Beard, April Proefrock, Brian Roedig, Bharat Damle, Stephen P Letrent, Arthur P DeCillis, and Neal J Meropol (Article)
Drug development in pancreatic cancer: finally, biology begets therapy., Steven J Cohen and Neal J Meropol (Article)
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations., Athanasios B-T Fassas, Firas Muwalla, Tanya Berryman, Riad Benramdane, Lija Joseph, Elias Anaissie, Rajesh Sethi, Raman Desikan, David Siegel, Ashraf Badros, Amir Toor MD, Maurizio Zangari, Christopher Morris, Edgardo Angtuaco, Sajini Mathew, Carla Wilson, Aubrey Hough, Sami Harik, Bart Barlogie, and Guido Tricot (Article)
Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients with Colon Carcinoma: A 10-Year Experience of the Geisinger Medical Center., Farid Fata, Ayoub Mirza, G Craig, Suresh G. Nair MD, Amy Law, James Gallagher, Neil Ellison, and Albert M. Bernath MD (Article)
p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation., Feng Gao, Tian-Li Yue, Dong-Wei Shi, Theodore A Christopher, Bernard L Lopez, Eliot H Ohlstein, Frank C Barone, and Xin L Ma (Article)
Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes., Vladimir Gotlib; Sanjay Singareddy; Usama Gergis MD, MBA; John Vakios; Elizabeth Guevara; Amy Chadburn; Leonid L Yavorkovsky; Arun Patel; Ahmar Butt; and Asha Nayak (Article)
Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer., Katherine A Harris, Elaine Harney, and Eric J Small (Article)
Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer., Katherine A Harris, Vivian Weinberg, Robert A Bok, Mika Kakefuda, and Eric J Small (Article)
A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia., Aminah Jatoi; Marisa Tria Tirona; Steven S. Cha; Steven R. Alberts MD, MPH; Kendrith M. Rowland; Roscoe F. Morton MD; Suresh G. Nair MD; Carl G. Kardinal MD; Philip J. Stella MD; James A. Mailliard MD; Daniel J. Sargent; and Richard M. Goldberg (Article)
Microscale assay for screening of inhibitory activity of Lactobacillus., Bradley Lash, Hassan Gourama, and Tami H Mysliwiec (Article)
Long-Term Survival of Patients with Advanced/Recurrent Carcinoma of Cervix and Vagina After Neoadjuvant Treatment with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the Addition of Molgramostim, and Review of the Literature., Harry J. Long, Sandra Rayson, Karl C. Podratz, Samir Abu-Ghazaleh, Vera J. Suman PhD, Lynn C. Hartmann MD, Ralph Levitt MD, Suresh G. Nair MD, Alan K. Hatfield MD, and James A. Knost (Article)
Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats., Christopher J Lynch, Susan M Hutson, Brian J. Patson MD, Alain Vaval, and Thomas C Vary (Article)
A phase II study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancer., Randolph S. Marks MD and Suresh G. Nair MD (Article)
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study., David J Moliterno, Steven J Yakubov, Peter M DiBattiste, Howard C Herrmann, Gregg W Stone, Carlos Macaya, Franz-Josef Neumann, Diego Ardissino, Jean-Pierre Bassand, Lynn Borzi, Alan C Yeung, Katherine A Harris, Laura A Demopoulos, and Eric J Topol (Article)
Clinical activity of arsenic trioxide for the treatment of multiple myeloma., N C Munshi, G Tricot, R Desikan, A Badros, M Zangari, Amir Toor MD, C Morris, E Anaissie, and B Barlogie (Article)
Women Experience Greater Toxicity with Fluorouracil-Based Chemotherapy for Colorectal Cancer., Jeff A. Sloan, Richard M. Goldberg, Daniel J. Sargent, Delfino Vargas-Chanes, Suresh G. Nair MD, Steven S. Cha, Paul J. Novotny, Michael A. Poon, Michael J. O'Connell, and Charles L. Loprinzi (Article)
Secondary hormonal manipulation of prostate cancer., Eric J Small and Katherine A Harris (Article)
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients., Amir Toor MD, A Slungaard, U Hedner, D J Weisdorf, and N S Key (Article)
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants., Guido Tricot, Trey Spencer, Jeffrey Sawyer, Dan Spoon, Raman Desikan, Athanasios Fassas, Ashraf Badros, Maurizio Zangari, Nikhil Munshi, Elias Anaissie, Amir Toor MD, and Bart Barlogie (Article)
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications., M Zangari, F Saghafifar, E Anaissie, A Badros, R Desikan, A Fassas, P Mehta, C Morris, Amir Toor MD, D Whitfield, E Siegel, B Barlogie, L Fink, and G Tricot (Article)
2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions., A Badros, B Barlogie, C Morris, R Desikan, S R Martin, N Munshi, M Zangari, J Mehta, Amir Toor MD, M Cottler-Fox, A Fassas, E Anaissie, S Schichman, and G Tricot (Article)
Images in clinical medicine. Bilateral ovarian dermoid cysts., Richard Boulay MD and E Podczaski (Article)
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone., K R Desikan, G Tricot, N C Munshi, E Anaissie, D Spoon, A Fassas, Amir Toor MD, M Zangari, A Badros, C Morris, D H Vesole, D Siegel, S Jagannath, and B Barlogie (Article)
Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches., T M Friedman, G Varadi, D D Hopely, J Filicko, J Wagner, A Ferber, J Martinez, J Brunner, D Grosso, L McGuire, R Korngold, and N Flomenberg (Article)
T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells., Amir Toor MD, T C Lund, and J S Miller (Article)
Infections during mobilizing chemotherapy and following autologous stem cell transplantation., Amir Toor MD, J A van Burik, and D J Weisdorf (Article)
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy., M Zangari, E Anaissie, B Barlogie, A Badros, R Desikan, A V Gopal, C Morris, Amir Toor MD, E Siegel, L Fink, and G Tricot (Article)
2000
A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas., Patrick A. Burch MD, Albert M. Bernath MD, Terrence L. Cascino, Bernd W. Scheithauer MD, Paul Novotny, Suresh G. Nair MD, Jan C. Buckner, Delano M. Pfeifle, John W. Kugler MD, and Loren K. Tschetter (Article)
Pancreatic cancer., S J Cohen, W H Pinover, J C Watson, and N J Meropol (Article)
A Phase II Study of Paclitaxel Plus Carboplatin as First-Line Chemotherapy for Women with Metastatic Breast Carcinoma., Edith A. Perez MD, David W. Hillman MS, Philip J. Stella MD, James E. Krook MD, Lynn C. Hartmann MD, Tom R. Fitch MD, Alan K. Hatfield MD, James A. Mailliard MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James N. Ingle MD (Article)
A Randomized Phase II and Pharmacokinetic Study of Dacarbazine in Patients with Recurrent Glioma., S. Vincent Rajkumar MD, Joel M. Reid, Paul J. Novotny, Stephanie L. Safgren, Bernd W. Scheithauer MD, P. Steven Johnson, Suresh G. Nair MD, Roscoe F. Morton MD, Alan K. Hatfield MD, James E. Krook MD, Matthew M. Ames, and Jan C. Buckner (Article)
Sex Differences in Fluorouracil-Induced Stomatitis., Jeff A. Sloan, Charles L. Loprinzi, Paul J. Novotny, Scott H. Okuno MD, Suresh G. Nair MD, and Debra L. Barton (Article)
Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation., Amir Toor MD, S Y Choo, and J A Little (Article)
1999
Alleviation of Gastrointestinal Mucosal Toxicity Related to Chemotherapy and Radiation Therapy: The NCCTG Experience., Scott H. Okuno MD, T Kozelsky, Charles L. Loprinzi, and Suresh G. Nair MD (Article)
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma., S. Vincent Rajkumar MD, Patrick A. Burch MD, Suresh G. Nair MD, Robert P. Dinapoli MD, Bernd W. Scheithauer MD, Judith R. O'Fallon MD, Paul S. Etzell MD, John M. Leitch MD, Roscoe F. Morton MD, and Randolph S. Marks MD (Article)
1998
Combined Levamisole with Recombinant Interleukin-2 (IL-2) in Patients with Advanced Renal Cell Carcinoma: A Phase II Study., Edward T. Creagan MD, Robert D. Hestorff, Vera J. Suman PhD, James A. Mailliard MD, Suresh G. Nair MD, James E. Krook MD, John W. Kugler MD, Robert F. Marschke, John C. Michalak, and Loren K. Tschetter (Article)
Cloning, expression, and characterization of a novel guanylate-binding protein, GBP3 in murine erythroid progenitor cells., B H Han; Don J. Park MD, PhD; R W Lim; J H Im; and H D Kim (Article)
Phase II Trial of Topotecan for the Treatment of Mesothelioma., Andrew W. Maksymiuk, Robert F. Marschke, Henry D. Tazelaar, Joe Grill, Suresh G. Nair MD, Randolph S. Marks MD, B. Jay Brooks, James A. Mailliard MD, G. Mark Burton, and James R. Jett (Article)
Primary Small Cell Anaplastic Carcinoma of the Breast Diagnosed by Fine Needle Aspiration Cytology: A Case Report., Matjaz Sebenik MD, Suresh G. Nair MD, and Husam F. Hamati MD (Article)
1997
Folate deficiency delays the onset but increases the incidence of leukemia in Friend virus-infected mice., M J Koury; Don J. Park MD, PhD; D Martincic; D W Horne; V Kravtsov; J A Whitlock; M del Pilar Aguinaga; and P Kopsombut (Article)
1996
Delayed Presentation of Breast Masses and Subsequent Treatment Compliance., Peggy E. Chatham-Showalter MD, Stephanie Knabbe, and Nora Suggs MD (Presentation)
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer., S C Remick, M Chmura, C Bromberg, J Sporn, B Healey, J Hilstro, R C DeConti, J Horton, J C Ruckdeschel, and G R Harper (Article)
1995
Morphogenetic gradients and Drosophila pattern formation, M S. Brose (Article)
Encouraging mammography use among underserved women through a celebration of breast health., B H Englisbe; G E Jimpson; Gregory R. Harper MD, PhD; and M Cohen (Article)
Pilot Study of Human Recombinant Interferon Gamma and Accelerated Hyperfractionated Thoracic Radiation Therapy in Patients with Unresectable Stage IIIA/B Nonsmall Cell Lung Cancer., Edward G. Shaw MD, Richard L. Deming MD, Edward T. Creagan MD, Suresh G. Nair MD, John Q. Su PhD, Ralph Levitt MD, Preston D. Steen MD, Martin Wiesenfeld MD, and James A. Mailliard MD (Article)
Trans- and cis-acting requirements for blastodermal expression of the head gap gene buttonhead., E A Wimmer, M Simpson-Brose, S M Cohen, C Desplan, and H Jäckle (Article)
1994
Induction of Squamous Differentiation by Interferon Beta in a Human Non-Small-Cell Lung Cancer Cell Line., Suresh G. Nair MD, Jane E. Mayotte, Anna Lokshin, and Mark L. Levitt (Article)
Synergy between the hunchback and bicoid morphogens is required for anterior patterning in Drosophila., M Simpson-Brose, J Treisman, and C Desplan (Article)